Citicoline (CDP-choline) is an endogenous nucleotide that serves as a biosynthetic precursor to phosphatidylcholine in neuronal membranes, used therapeutically to support cognitive function, neurological recovery after stroke, and as a neuroprotective supplement. Simson Pharma's Citicoline reference standard and impurities support potency and purity testing of these neurological formulations.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Citicoline Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.